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Aquaporin 11, a regulator of water efflux at
retinal Müller glial cell surface decreases
concomitant with immune-mediated gliosis
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Abstract
Background: Müller glial cells are important regulators of physiological function of retina. In a model disease of
retinal inflammation and spontaneous recurrent uveitis in horses (ERU), we could show that retinal Müller glial cells
significantly change potassium and water channel protein expression during autoimmune pathogenesis. The most
significantly changed channel protein in neuroinflammatory ERU was aquaporin 11 (AQP11). Aquaporins (AQP, 13
members) are important regulators of water and small solute transport through membranes. AQP11 is an
unorthodox member of this family and was assigned to a third group of AQPs because of its difference in amino
acid sequence (conserved sequence is only 11 %) and especially its largely unknown function.
Methods: In order to gain insight into the distribution, localization, and function of AQP11 in the retina, we first
developed a novel monoclonal antibody for AQP11 enabling quantification, localization, and functional studies.
Results: In the horse retina, AQP11 was exclusively expressed at Müller glial cell membranes. In uveitic condition,
AQP11 disappeared from gliotic Müller cells concomitant with glutamine synthase. Since function of AQP11 is still
under debate, we assessed the impact of AQP11 channel on cell volume regulation of primary Müller glial cells
under different osmotic conditions. We conclude a concomitant role for AQP11 with AQP4 in water efflux from
these glial cells, which is disturbed in ERU. This could probably contribute to swelling and subsequent severe
complication of retinal edema through impaired intracellular fluid regulation.
Conclusions: Therefore, AQP11 is important for physiological Müller glia function and the expression pattern and
function of this water channel seems to have distinct functions in central nervous system. The significant reduction
in neuroinflammation points to a crucial role in pathogenesis of autoimmune uveitis.
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Background
Autoimmune uveitis is a neuroinflammatory disease that
is characterized by recurrent remitting episodes of intra-
ocular inflammation [1]. Targets of the immune attacks,
that are mainly carried out by autoaggressive T cells, are
retinal proteins [2, 3]. Since the retina belongs to the
central nervous system, every damage of its architecture
means irreversible destruction and subsequently impairs
visual function. Main actors from immune system are T
helper cells (CD4+) [4]. Additionally, B cells participate
through autoantibodies [2] and cells of the innate im-
mune system also contribute to pathophysiology [5]. To
current knowledge, there are T helper cell subsets from
Th1 and Th17 pathways involved in this progressive,
organ-specific autoimmune disease pathology [4, 6–8].
The role of retinal cells itself in sight-threatening com-
plications during inflammation has lately gained more
interest, since it was shown that intraocular inflamma-
tion is the result of interplay between cells of the retina
and cells of the immune system. Invasion of retina by
immune cells and subsequent reversible destruction of
this central nervous system-associated tissue is also crit-
ically dependent on the response of cells from the retina
itself [9]. Without correspondent reaction of retinal cells,
autoaggressive immune cells alone will not lead to invasion
and intraocular inflammation [9]. We identified retinal
Müller cells, the dominant macroglial cells of the retina as
decisive cells in uveitis immune pathology [10, 11].
Through proteome analyses of changed membrane
proteins in ERU retina, we identified numerous differen-
tially expressed proteins in disease [12]. A cluster of
changed channel membrane proteins was identified, and
we subsequently verified and further characterized re-
spective differential expression [10]. Interestingly, mostly
retinal Müller glial cells were related to changed abun-
dance and distribution of potassium channels (Kir 2.1
and 4.1), as well as two aquaporins (4 and 5) [10].
Aquaporins are integral membrane proteins with 13
members to date [13]. Aquaporins generally control
water transport and transcellular water flow and are im-
portant regulators of cellular volume [14]. A rapid
change of cellular volume always provokes a reaction by
aquaporins [14]. Aquaporins can be assigned to three
different functional groups, the first comprises orthodox
aquaporins, that primarily transport water (AQP0, 1, 2,
4, 5, 6, 8) [13]. The second group contains aquaglycero-
porins (AQP3, 7, 9, 10) that passage water and neutral
solutes [13]. The third group encloses only two members
so far, AQP11 and 12; both are only distantly related to
the other aquaporins and have low amino acid sequence
similarities to the proteins of both other groups [13].
Interestingly, we found AQP11 as the most signifi-
cantly regulated channel protein in enriched membrane
fraction of ERU retina. AQP11 is the latest member of
the aquaporin family, was shown to be localized to the
plasma membrane [15], and is presumed to have an im-
portant role in endoplasmatic reticulum (ER) function
[16]. AQP11 knockout mice die due to a malfunction of
their kidneys with degeneration of proximal tubule cells
[17]. Further, AQP11 was shown to prevent glucose-
induced oxidative stress in proximal tubules [18].
Besides other organs, AQP11 was also shown to be
expressed in the eye [19], but in general, the function of
AQP11 is still largely unknown [13]. Since biological
functions of AQP11 remain to be elucidated and our
finding was the first evidence pointing to an important
role of AQP11 in a spontaneously occurring neuroin-
flammatory disease involving the retina, we were inter-
ested to gain further insight into the role of AQP11.
Retinal edema is a severe complication of recurrent uve-
itis [20]. Since Müller glial cells are important regulators
of intraretinal water flow [21] and aquaporins provide
one important mechanism for water movement, the goal
of this study was to test the hypothesis that AQP11
function plays a critical role in the context of inflamma-
tion and osmotic stress in the eye.
Methods
Specimen
For this study, a total of 78 healthy controls and 33 ERU
eyes and were used (Western blots, 11 controls, 12 ERU;
immunohistology, 11 controls, 21 ERU; immune cytology,
46 controls). ERU specimens were derived from horses
that were treated in the equine clinic and diagnosed with
ERU according to clinical criteria as described [22]. All
eyes used for this study were from animals that were
euthanized due to causes unrelated to this study (control
and ERU eyes). These causes were evenly distributed in
both groups (controls and ERU cases) and did not involve
systemic inflammatory or neurological conditions (e.g.,
chronic degenerative lameness). Three ERU eyes were
immediately enucleated after a therapeutical procedure
(vitrectomy) because of death in general anesthesia. Re-
moval of vitreous or the respective chronic diseases did
not influence the retinal structure for this study. Collection
and use of equine eyes from animals that were killed due
to a research-unrelated cause was approved for purposes
of scientific research by the appropriate board of the veter-
inary inspection office Munich, Germany (permit number:
8.175.10024.1319.3). All animals were treated according to
the ethical principles and guidelines for scientific experi-
ments on animals according to the ARVO statement for
the use of animals in Ophthalmic and Vision Research. No
experimental animals were involved in this study.
Sample preparation
Immediately after enucleation, retinas were isolated from
the eyeballs as described [10]. For the preparation of
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lysates for western blots, retinas were immediately
stabilized with protease inhibitors (Roche, Mannheim,
Germany), homogenized, lyophilized ,and subsequently
dissolved in lysis buffer (9 M urea, 2 M thiourea, 65 mM
DTT, 4 % CHAPS). Protein content was determined
using the Bradford assay (Sigma-Aldrich, Taufkirchen,
Germany).
For the preparation of primary retinal Müller glial cells
for cell culture experiments, these cells were separated
from the retinal tissue as previously described [23]. In
brief, retinal tissue fragments were incubated at 37 °C
with papain for 30 min (Roth, Karlsruhe, Germany).
Papain activity was induced with 1.1 μmol EDTA,
0.067 μmol mercaptoethanol, and 5.5 μmol cysteine-
HCL for 30 min at 37 °C prior to use. The reaction was
stopped by adding DMEM with 10 % fetal calf serum
(PanBiotech, Aidenbach, Germany). After addition of deso-
xyribonuclease I (Sigma-Aldrich, Taufkirchen, Germany)
and trituration, the cells were collected by centrifugation
(800 g, 10 min, RT), resuspended in DMEM with 10 % FCS
and 1 % penicillin/streptomycin (all PanBiotech, Aidenbach,
Germany), and seeded into 25-cm2 flasks (Sarstedt,
Nümbrecht, Germany). After attachment for 24 h, cells
were purified through repeated vigorous washing and
removal of supernatant containing non-attached neur-
onal cells.
For immunohistochemical stainings, posterior eyecups
were sliced into pre-assigned pieces as described [24],
fixed in Bouin’s solution (Applichem, Darmstadt,
Germany), and dehydrated in a series of alcohols. Result-
ing tissue blocks were embedded in paraffin, sectioned
(8 μm), and mounted on coated slides (Superfrost Plus,
Medite, Burgdorf, Germany). For validation of AQP11
antibody, we further used sections from negative control
mouse and rat eyes and mouse kidney from earlier ex-
periments. These specimens were also fixed in Bouin’s
solution.
Antibodies
A novel mouse monoclonal antibody clone 8H9 to
AQP11 was generated towards a linear 12mer epitope of
horse AQP11 in a widely conserved sequence. The anti-
body is cross-reactive to human, mouse, and rat AQP11;
its isotype is mouse IgG1. For detection of Müller glial
cells, we additionally used mouse antiglutamine synthase
(GS) antibody (BD Biosciences, Heidelberg, Germany)
and for detection of reactive gliosis, we used rabbit anti-
glial fibrillary acidic protein (GFAP; Sigma-Aldrich,
Taufkirchen, Germany) antibody. As loading control and
for normalization, we used mouse antibeta-actin antibody
(Sigma-Aldrich, Taufkirchen, Germany) or mouse anti-
GAPDH antibody (Merck-Millipore, Darmstadt, Germany).
For inhibition of AQP4, we used mouse anti-AQP4 (Santa
Cruz, Heidelberg, Germany); for blockage of AQP5, we
used rabbit anti-AQP5 (Chemicon, Darmstadt, Germany)
antibodies. AQP4 and 11 inhibitions through anti-AQP4
and AQP11 antibodies in cell culture experiments were
controlled with mouse IgG isotype control antibodies;
AQP5 inhibition was controlled with rabbit IgG. As sec-
ondary antibodies, anti mouse IgG HRP antibody was used
for western blots and conventional immunohistochemical
staining, and goat anti rabbit IgG Alexa 647 1:500, goat
anti mouse IgG1-FITC 1:200, or goat anti mouse IgG
coupled to Alexa 546 1:500 (all from Invitrogen, Karlsruhe,
Germany) were taken for immunohistochemistry and
cytology.
Quantification of AQP11 expression with western blots
PVDF membranes (GE Healthcare, Freiburg, Germany)
were loaded with equal total protein amounts from ret-
inal lysates after separation by SDS-PAGE (12 % gels)
and semidry blotting. To prevent unspecific binding,
membranes were blocked with 4 % bovine serum albu-
min for 1 h at room temperature. Blots were then incu-
bated with primary antibody (undiluted supernatant of
novel anti-AQP11 clone 8H9) or with anti-beta actin
antibody (dilution 1:50,000) or with anti-GAPDH anti-
body (dilution 1:500). After incubation with secondary
HRP-coupled antibody for 1 h at room temperature, sig-
nals were detected by enhanced chemiluminescence on
X-ray films (Fuji; Christiansen, Planegg, Germany).
Films were scanned on a transmission scanner, and
quantification of western blot signals by densitometry
was performed using ImageQuantTL software (GE
Healthcare, Freiburg, Germany). AQP11 abundances
were normalized to beta actin to ensure comparison of
equally loaded cells, and subsequently, expression
differences between ERU cases and controls were statis-
tically analyzed using Student’s t test. Differences in pro-
tein expression were considered significant, if p value
was ≤0.05.
Analyses of AQP11 expression in healthy and diseased
eyes
For detection of AQP11 in eyes from our paraffin-
embedded tissue bank of physiological control eyes and
ERU cases from various stages of disease, heat antigen
retrieval was performed at 99 °C for 15 min in 0.1 M
EDTA-NaOH buffer (pH 8.0). For prevention of unspe-
cific antibody binding, sections were initially blocked
with 1 % BSA in TBS-T and 5 % normal goat serum.
Blocking serum was chosen according to the species
the secondary antibody was produced in. Cell nuclei
were counter-stained with DAPI (Invitrogen, Karlsruhe,
Germany) or hematoxylin. For multiple labeling, blocking
steps (ProteinBlock; DakoCytomation, Hamburg, Germany)
were applied before every antibody incubation. For
fluorescence triple labeling, sections were sequentially
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incubated with primary antibodies (AQP11 4 °C overnight;
glutamine synthase 1:1500 and GFAP 1:1000 for 3 h at
RT), always followed by respective secondary antibodies
(30 min at RT). Finally, the sections were mounted with
glass coverslips using fluorescent mounting medium (Carl
Roth, Karlsruhe, Germany). Fluorescent images were
recorded with Axio Imager M1 or Z1 and software Axio
Vision 4.6 (Zeiss, Göttingen, Germany). Sections for the
conventional immunohistology were stained with Vector
VIP staining kit (Biozol, Eching, Germany) and recorded
with Leica DMR microscope (Leica, Wetzlar, Germany).
For all stainings, negative controls were performed with
isotype controls of irrelevant specificity. To assess epitope
specificity of our novel AQP11 antibody, we performed
preincubation experiments with rising concentrations
(1, 10, 100 μg/ml antibody supernatant) of the AQP11
immunization peptide with the AQP11 antibody (for
30 min at 37 °C). As a negative control, we used even
concentrations of irrelevant CD3 peptide for prein-
cubation. Binding capacity of preincubated antibodies was
then analyzed with fluorescence immunohistochemistry,
and intensity was compared to straight AQP11 antibody
staining.
Functional analyses of AQP11 in primary retinal Müller
glial cells
To investigate AQP11 function in primary retinal Müller
glial cells, we seeded 1 × 104 cells per well in sterile mul-
tichamber slides (Millicell EZ 8-well glass slides, Merck
Millipore, Darmstadt, Germany). Cells were then chal-
lenged with hyperosmolar (DMEM with 30.8 mmol
NaCl), hypoosmolar (DMEM diluted with aqua dest.
1:5), or hyperglycemic (DMEM with 25 mmol glucose)
conditions for 30 min. After thorough washing, cells
were fixed with 2 % PFA for 30 min on ice. Then, cells
were stained with both hematoxylin and eosin (Roth,
Karlsruhe, Germany). Images were recorded with either
Leica DMR (40× objective magnification) or Axio Vision
Imager M1 (40×), and resulting images were imported
into Adobe Photoshop software for further analyses. Re-
spective measurements were used to calculate and com-
pare cell and organelle sizes between the different
conditions. To identify the role of AQP11 in regulation
of cell size in these states, we blocked AQP11 through
preincubation of cells with our monoclonal antibody and
compared the response to inhibition with respective
antibodies to AQP4 (Santa-Cruz, Heidelberg, Germany,
1:50) or AQP5 (Merck-Millipore, Darmstadt, Germany,
1:200). As negative control, we used preincubation with
isotype control antibodies. Cell size areas and that of
nuclei of each condition were measured. A total of 46
biological replicates with 10 cells each were com-
prised in the statistical analysis per approach. Mann-
Whitney test was performed for comparison of cell
size in physiological condition and after osmotic chal-
lenge. The results were regarded as significant, if the
p value was ≤0.05.
Results
Aquaporin 11 is the most significantly regulated channel
protein in uveitic retina
In an earlier study, we detected differentially regulated
candidates in membrane protein-enriched fractions of
healthy retina compared to ERU [12]. Among channel
proteins, aquaporin 11 (AQP11) was the protein with
most changed abundance in disease (Table 1). Since
AQP11 is a protein which function is still discussed and
this was the first association of this protein with an
autoimmune disease, we were interested to further
characterize the meaning of AQP11 downregulation for
ERU pathogenesis.
Establishment of novel antiaquaporin 11 antibody
For characterization of AQP11 function in equine retina,
we first generated an antibody suited for a respective
AQP11 detection. Clone 8H9 proved to identify equine
AQP11 (controlled by immune precipitation with equine
retinal lysate and subsequent detection of AQP11 by
mass spectrometry, data not shown) with all techniques
applied for this study (western blots, immunohistochem-
istry/cytology and blocking of AQP11).
Aquaporin 11 is exclusively expressed at retinal Müller
glial cells in the retina
In retinal sections, we subsequently detected AQP11
expression specifically at retinal Müller glial cells (Fig. 1a,
AQP11 red, endfeet located in ganglion cell layer = GCL,
arrow). AQP11 was distributed all over the cell, with
strong signals at endfeet, ending with a fainter expression
Table 1 Identification and regulation of AQP11 protein in healthy compared to ERU retina as assessed by mass spectrometry
Protein namea Accession no.b Confidence scorec Peptide countd Anovae Ratio control/ERUf
Aquaporin-11 ENSECAP00000015158 241 3 p ≤ 0.001 4.56
aProtein name
bAccession number as listed on Ensembl database (http://www.ensembl.org/index.html)
cConfidence score as given in Mascot
dNumber of peptides used for identification
eSignificance of differential expression of proteins in healthy cases compared to control by Anova
fRegulation factor
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at outer limiting membrane (=OLM, Fig. 1a, arrowhead).
Apart from RMG cells, no other structures of the retina
were positive for AQP11, as tested for example for endo-
thelial cells by costaining with Lycopersicon esculentum
lectin, a vascular endothelial marker in horses [25], which
did not result in an overlap. In contrast, double staining
with vimentin, a Müller glia cell marker (Fig. 1c, green),
resulted in clear overlap with AQP11 (Fig. 1c, red) expres-
sion (Fig. 1c, yellow color). A high magnification image
with peroxide color staining enabled the exact localization
of AQP11 along Müller glial cell membrane (Fig. 1d,
AQP11: violet). Preincubation of AQP11 antibody with
Fig. 1 Assessment of AQP11 expression with immunohistochemistry, scale bars = 20 μm. a Expression in equine retina. AQP11 (red) was specifically
expressed at retinal Müller glial cells, reaching from endfeet in ganglion cell layer to outer limiting membrane; ILM inner limiting membrane (arrow),
GCL ganglion cell layer, IPL inner plexiform layer, INL inner nuclear layer, OPL outer plexiform layer, ONL outer nuclear layer, OLM outer limiting
membrane (arrowhead). b Negative control, incubated only with secondary antibody anti mouse IgG Alexa 568. c Overlay of Müller glia marker
vimentin (green) and AQP11 expression (red) in equine retina results in yellow color. d Müller glia cell membrane localization of AQP11 (violet) stained
with fine-grained resolution. e Preincubation of AQP11 antibody with 100 μg/ml irrelevant peptide did not interfere with antibody binding, AQP11:
red. f Preincubation with 100 μg/ml AQP11 immunization peptide completely blocked antibody binding. g Preincubation with 1 μg/ml AQP11
immunization peptide partly blocked antibody binding. h Müller glia endfeet of mouse and i rat retina express AQP11 (red). j AQP11 (red) expression in
positive control tissue mouse kidney
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immunization peptide, but not with irrelevant peptide
dose dependently omitted binding of antibody to AQP11
(Fig. 1e, preincubation with 100 μg/ml irrelevant peptide,
1F: preincubation with 100 μg/ml AQP11 peptide, 1G:
1 μg/ml AQP11 peptide). AQP11 prominently labeled the
entire Müller glia cells in horse retina, expanding along
Müller cell bodies until the outer limiting membrane. This
is different to the description in human retina, where
AQP11 was primarily detected at the inner limiting mem-
brane formed by Müller cell endfeet [26]. However, both
species present with Müller cell-specific AQP11 expres-
sion as observed by immunostaining. We have observed
before that other marker proteins (GFAP, Glutamine syn-
thase) label the entire structure of Müller cells in normal
horse retina [2, 11], while in other species as mouse [27],
rat [2], and human [28], only marginal staining close to
the endfeet is visible. Therefore, AQP11 also labels Müller
glia cells in mouse (Fig. 1h, AQP11: red) and rat retina
(Fig. 1i, AQP11: red). AQP11 was also detectable in mouse
kidney, a positive control tissue for AQP11 expression
(Fig. 1j, AQP11: red).
Expression of AQP11 profoundly decreases in recurrent
uveitis
We next verified significant reduction of AQP11 expres-
sion in ERU cases, since our initial finding of AQP11 de-
cline as most significantly reduced channel protein in
ERU prompted us to analyze AQP11 function in retina.
Quantification of AQP11 in healthy retinas versus ERU
cases confirmed profound reduction of AQP11 expres-
sion in diseased retinas to 32 % of physiological expres-
sion (Fig. 2, white bar: controls, grey bar: ERU cases).
Triple staining of healthy (Fig. 3a) and uveitic retinas
(b, differential interference contrast images) with gliosis
markers GFAP (Fig. 3c, d, violet) and GS (Fig. 3e and f,
green) revealed typical gliosis reaction of retinal Müller
glial cells in inflammatory condition. GFAP was clearly
upregulated in ERU (Fig. 3d) concomitant with lower
abundance of GS in these cells (Fig. 3f). Interestingly, the
decrease of AQP11 followed GS expression pattern in all
tissues analyzed (Fig. 3h, representative image of 21 ERU
eyes, AQP11: red). Therefore, we conclude that reduction
of AQP11 is indicative of gliotic Müller cells from our
analyses.
AQP 11 regulates cell volume through water efflux in
Müller glial cells
Since the function of AQP11 is still under debate in
many animals and different cell types, we were inter-
ested to analyze AQP11 function in native equine Müller
glial cells. Therefore, we analyzed cell volume regulation
of these cells under different osmotic challenges and cre-
ated hyperglycemic, hypotonic, and hypertonic environ-
ments in cell culture. To assess AQP11 function in these
conditions, we blocked AQP11 function with our novel
monoclonal antibody and compared the effects to inhib-
ition of AQP4 and 5, respectively. All applied settings
led to a significant change in cell areas (Fig. 4). Hyper-
glycemic (Fig. 4a) and hypotonic environments (Fig. 4b)
led to significant regulatory volume increase of Müller
glial cells (Fig. 4a: factor 1.8, ***p ≤ 0.001, 4b: factor 1.7,
**p ≤ 0.01) and hypertonic environment to a regulatory
volume decrease (Fig. 4c: factor 0.7, ** = p ≤ 0.01).
Blockage of AQP11 water channel did not prevent the
swelling of cells under hyperglycemic and hypotonic
conditions (Fig. 4a, b, red bars). In contrast, in hypotonic
environment, only inhibition of AQP5 averted the in-
crease of cell nuclei (Fig. 4b, green bar). But in hyper-
tonic condition, shrinking of cells was totally abolished
through inhibition of AQP11 channels (Fig. 4c, red bar,
**p ≤ 0.01). Inhibition of AQP4 was also selectively effi-
cient to prevent cell shrinking in hypertonia (Fig. 4c,
blue bar, **p ≤ 0.01), whereas blockage of AQP5 did sig-
nificantly change cellular reaction to hypotonic environ-
ment (Fig. 4b, green bar, ***p ≤ 0.001). Therefore, AQP5
seems to have another direction in cell volume regula-
tion of Müller glia cells, whereas AQP4 and 11 seem to
have similar functions in cell volume control. Morph-
ology of Müller glial cells changed accordingly (Fig. 5).
Hyperglycemic and hypotonic media led to swelling of
cell bodies (Fig. 5b, c) and hypertonia to cell volume de-
crease (Fig. 5d). Only the latter phenotype was rescued
by preincubation of cells with anti-AQP11 antibody,
which blocked the respective water channel (Fig. 5e–g).
Control incubation with isotype antibody did not result
in cell volume change (Fig. 5b–d).
Fig. 2 Marked decline of AQP11 protein expression in ERU retinas,
scale bars = 20 μm. Western blot analyses demonstrated that in
inflamed retinas; AQP11 abundance was reduced to one third
(31 ± 33 %) of physiological quantity (*p ≤ 0.05). White bars represent
quantified expression of AQP11 in control retinas (n=), grey bars of
ERU retinas (n=). Entire blot strips of retinal proteins of representative
control horse and ERU case beside respective bars. The blots were first
incubated with anti-AQP11 antibody (lower band) and then with beta
actin antibody (upper signal) for normalization
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Fig. 3 (See legend on next page.)
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Discussion
In addition to potassium (Kir 2.1 and 4.1) and water
(AQP4 and 5) channel proteins found differentially
expressed in retinal membrane proteins of horses with
ERU by us [12], we detected AQP11 as the most signifi-
cantly downregulated candidate in pathological condition
of ERU. AQP11 is a very interesting water channel protein
because it is quite different to most of the other members
of aquaporin family proteins [13]. An exception is AQP12
that shares similarities with AQP11, at least regarding the
unusual N-terminal sequence with an NPA (asparagine-
proline-alanine) motif and low homology to the other
aquaporins [13, 16]. AQP11 was primarily described as
not only most abundantly expressed in testis and to a
lower extent, but also prominent in the kidney, liver, and
brain [29]. AQP11 knockout mice die early because of
renal failure and retarded growth [30]. An ocular pheno-
type was not described in these mice so far [30]. Neverthe-
less, all aquaporins were reported to be expressed in the
eyes of several mammals analyzed [31]. AQP11 is
expressed at Müller glia endfeet in the eyes of humans
[26]. In this study, we could clearly confirm AQP11 ex-
pression for Müller glia endfeet, but additionally, AQP11
is expressed throughout entire Müller glia plasma cell
membrane in horse retina (Fig. 1a, c, d). After we identi-
fied AQP11 as the most pronounced downregulated chan-
nel protein in retinal membrane protein fraction (Table 1)
in a differential proteomics experiment analyzing physio-
logical retina versus autoimmune diseased retina in a
spontaneous horse model [12], we were quite interested in
the exact cellular localization and function of this less
good characterized member of the aquaporin family [32].
(See figure on previous page.)
Fig. 3 AQP11 expression reduction is associated with gliotic changes in ERU retinas, scale bars = 20 μm. ILM inner limiting membrane (arrow), GCL
ganglion cell layer, IPL inner plexiform layer, INL inner nuclear layer, OPL outer plexiform layer, ONL outer nuclear layer, OLM,outer limiting membrane
(arrowhead). In uveitis, AQP11 expression decreases secondary to gliosis. a Physiological retina. b ERU. c GFAP (violet) expression in healthy Müller glial
cells. d Upregulation of GFAP (violet) in gliotic Müller cells in ERU. e GS (green) expression in control Müller cells. f Reduction of GS (green) in gliotic
Müller cells in ERU. g Physiological AQP11 (red) expression in control retina. h Decline of AQP11 contrary to GFAP upregulation in ERU indicates
diminished AQP11 in gliotic Müller cells; overlay image of GFAP (violet), GS (green), and AQP11 (red) in i physiological control retina and j ERU retina.
i In healthy retina, Müller cell markers and AQP11 widely colocalize (triple overlay =white color). j In contrast, in ERU, gliosis dominates with upregulation
of GFAP (violet) and concomitant loss of GS (green) and AQP11 (red), (triple overlay =white color)
Fig. 4 AQP11 plays a role in cell volume regulation of Müller glial cells. Hyperglycemic (a), hypotonic (b), and hypertonic (c) extracellular environments
led to significant respective cell volume regulations. Inhibition of AQP4 (blue bar), AQP5 (green bar), or AQP11 (red bar) did not change cellular response
under hyperglycemic conditions (Fig. 4a). Under hypotonia, only blockage of AQP5 rescued the cells from swelling (Fig. 4b, green bar). In contrast,
inhibition of AQP4 and AQP11 channels did not change reaction in hyperglycemia and hypotonia (Fig. 4a, b) but significantly prevented reduction of
cell size in hypertonic condition (Fig. 4c, blue bar AQP4, red bar AQP11). **p≤ 0.01; ***p≤ 0.001
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Therefore, we developed respective antibody to horse
AQP11 that allows detection of AQP11 in paraffin-
embedded sections (Figs. 1 and 3) and western blots
(Fig. 2) and to block AQP11 function in native Müller glial
cells (Figs. 4 and 5). This was important because tissue
localization and functional studies about unorthodox
aquaporins in general are currently hampered because of
poor-quality antibodies available [17, 33–35]. Our novel
monoclonal antibody is well suited to analyze AQP11 ex-
pression in immunohistochemistry and will probably aid
other researchers interested in characterization of AQP11
in other animals or organs, since there is a reported lack
of a good antibody suited for immunohistochemistry so
far (positive stainings with antibody 8H9 in other species/
tissues: Fig. 1h: mouse retina, i: rat retina, j: mouse
kidney). With our novel tool, we could confirm marked
reduction of AQP11 expression in a spontaneous model
of retinal inflammation (ERU) to one third of physiological
amount in retinas (Fig. 2). AQP11 was selectively
expressed in retinal Müller glial cells in the retina of
horses (Figs. 1a, c and 3g) and especially declined (Fig. 3h)
in the areas of Müller cell gliosis (Fig. 3d, f) characterized
in situ through upregulation of GFAP and concomitant
lower expression of glutamine synthase in ERU (Fig. 3d, f).
Reduction of AQP11 expression in ERU (Fig. 3h) closely
followed glutamine synthase expression in respective areas
(Fig. 3f, overlay j). Since Müller glial cells are still present
in these regions, AQP11 reduction is not secondary to loss
of expression sites, but seems to be related to
inflammation-associated gliosis (Fig. 3). To our knowledge,
this is the first link of AQP11 to a spontaneous auto-
immune disease and in neuroinflammation. Because
AQP11 function is still debated and ranges from it have
no water permeability ability at all, as shown with Xenopus
oocytes expressing AQP11 [15] or has low but normal
water channel activity with mercurial sensitivity, we were
interested to test the influence of AQP11 to water perme-
ability in Müller cells. Our results clearly show that
AQP11 channel is especially important during osmotic
stress conditions and blockage of respective channel pro-
tein results in the rescue from cell shrinking in extracellu-
lar hypertonic conditions (Figs. 4 and 5). Inhibition of
AQP4 showed the same results as application of anti-
AQP11 antibody, a selective saving from shrinking in
hypertonic milieu, whereas blockage of AQP5 positively
influenced cellular behavior in hypotonic environment
(Fig. 4). Further, we could clearly show that AQP11 is
expressed at Müller glial plasma cell membrane (we
additionally confirmed the expression of AQP11 at Müller
glia endfeet in mouse and rat retina). AQP11 expression
was detected intracellularly [31, 32] in many organs of
other species, especially at rough ER [36, 37]. Interestingly,
we could not discover AQP11 at Müller glial cell ERs, as
tested with ER markers calreticulin and calnexin in double
stainings with AQP11, nor with various other cell organelle
markers tested (e.g., for mitochondria, ribosomes, Golgi a.
o., analyzed with apotome) or other cell types like endothe-
lial cells (costaining with specific plant lectins). Therefore,
we conclude that AQP11 is preliminary expressed at the
cell surface of Müller glial cells. This would indicate an
interesting difference of AQP11 in various cell types. But so
far, several discrepancies in AQP distribution have been re-
ported for different cells and tissues, including its location
within lung and airways, gut, and exocrine glands [38],
underscoring the need for further analyses regarding cellu-
lar and subcellular distribution of AQP11. For example,
localization of AQP11 at the plasma cell membrane re-
mains controversial for other cells. Immunocytochemistry
Fig. 5 Blockage of AQP11 prevents shrinking of cells in hypertonic environment, scale bars = 20 μm. Primary native retinal Müller glial cells (a) were
incubated in different osmotic stress conditions (b hyperglycemia, c hypotonia, d hypertonia) and initiated cell volume regulation. e–g Respective
osmotic stress condition of cell above, but with inhibition of AQP11 channel through preincubation with AQP11 antibody. Only shrinkage under
extracellular hypertonia (d, g) was inhibited with anti-AQP11 antibody preincubation (e–g). Staining of cells: H&E
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was used to show the expression of AQP11 on the cell sur-
face of transfected Chinese hamster ovary cells [15],
whereas other data indicated that AQP11 is not targeted to
the plasma membrane and stays intracellularly [36]. In
liver-specific AQP11 knockout mice, immunoblotting of
membrane proteins from control mouse liver indicated
AQP11 in this fraction, but exact cellular localization could
not be investigated in this study because their antibody was
not suited for immunohistochemistry [17]. Probably, this
information can now be created with our novel antibody
and therefore shed more light on the unclear biological
function of this interesting membrane channel protein.
Most studies focused on the role of AQP11 in ER
function so far. It was shown that disruption of AQP11
in knockout mice leads to apoptosis in kidney cells asso-
ciated with upregulation of ER stress genes [39]. In
Müller glial cells, AQP11 is expressed at cell surface and
its significant reduction in ERU will therefore result in a
change in transport function through plasma cell mem-
brane. In our study with primary Müller glial cells, we
could clearly show a function in cell volume regulation
after osmotic stress to the cells. Blockage of AQP11 to-
tally abolished the shrinking of treated cells (Figs. 4 and
5) like AQP4 did, indicating a similar function for both
AQPs in outward water transport of retina. Redundant
expression of different aquaporins was also shown for
other tissues, e.g., of AQP3 and AQP4 in the basolateral
plasma membrane of collecting duct principal cells,
where they colocalize [38]. The functional meaning of
such coexpression is not fully understood to date. Since
these channels also transport some other compounds
besides water, there could be some other functional dif-
ferences. The data concerning the ability of AQP11 to
transport water are conflicting, and there is a lack of
knowledge about the permeability of AQP11 to other
solutes [15, 40]. Therefore, the meaning of AQP4 and
AQP11 coexpression und probable cofunction in the ret-
ina needs further investigation in our opinion.
We earlier observed in ERU retinas that the total amount
of AQP4 increased, whereas AQP5 decreased [10]. But
interestingly, AQP4 expression changed its localization in
ERU from Müller cells to a strong circular expression in
the outer nuclear layer and rarely in the inner nuclear layer,
whereas its expression in Müller cell trunks almost disap-
peared [10]. Since our proteome analyses of healthy and
ERU retinas did not indicate further AQPs besides 4, 5, and
11 in physiological or ERU condition [12], the question
arises, how ERU retinas handle water control without these
aquaporins. Probably, water flow is still controlled by AQP4
despite re-localization, although we cannot entirely rule out
other pathways/channels [38] capable of water transport in
retinal pathophysiology.
Previously, we already identified a loss of potassium
(Kir 2.1 and 4.1) and water channels (AQP4 and 5) in
gliotic Müller glial cells in ERU [10]. Retinal edema is a
severe complication of late-stage ERU [20] and can be
caused by swollen Müller glial cells [21]. Severe cases of
gliosis induce the de-differentiation of Müller glial cells,
followed by impairment of the ion and water homeosta-
sis after downregulation of K+ channels [21]. Downregu-
lation and changed expression of Kir channels already
takes place in early stages of ERU [10]. Downregulation
of these K+ channels can subsequently inhibit K+ release
into the blood and interrupt the dehydrating K+ cur-
rents through Müller cells, which can increase the
osmotical pressure within the cells. This results in an
osmotic difference at the gliovascular interface which
favors water inflow into the cells via still expressed aqua-
porin (especially AQP4) water channels [21]. Osmotic
stress can then activate phospholipase A2 and arachi-
donic acid (or inflammation during ERU) and can fur-
ther increase theinflux of Na+ ions and therefore create
an osmotic driving force for water inflow into the cells,
resulting in Müller cell swelling [21]. These mechanisms
lead to significant dysregulation of retinal dehydration
by Müller cells and to exacerbation of intra- and extra-
cellular fluid accumulation [21]. The loss of AQP11
channels at Müller glia plasma cell membranes (Fig. 3)
probably reduces the ability of the cells to reduce cell
volume through outflow of water and therefore leads to
cell swelling and subsequent fatal retinal edema not only
in ERU but also other retinal diseases, e.g., diabetic
macular edema.
The role of AQP11 could additionally be tested by
administering recombinant AQP11 to the cells in the in
vitro studies. Although we have recently established
virus-based transduction protocols with the hope to
overcome the minimal transfection efficiencies observed
for primary Müller cells (from horse and pig), we so far
only achieved low transduction rates with lentivirus
(maximal 5 %) and consequently at this time, those ex-
periments are not feasible. But in future studies, we plan
to study the effect of adding AQP11 to the cells under
different environmental conditions in vitro.
Conclusions
Our finding of most downregulated water channel
AQP11 in a retinal autoimmune disease is novel and
very interesting in our point of view because it links this
poorly characterized protein to a role in retinal Müller
glial cell function in a spontaneous inflammatory eye
disease. Further, we could assign AQP11 expression spe-
cifically to retinal Müller glial cell plasma cell mem-
branes and demonstrate a function for cell volume
regulation through outward water transport. Since
AQP11 is also selectively expressed in brain endothelium
that forms blood-brain barrier and is important for the
prevention of brain edema [34], the expression pattern
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and function of this water channel seems to have distinct
and important functions in the central nervous system.
The finding of decreased abundance in the context with
neuroinflammation in a spontaneous autoimmune dis-
ease indicates its relevance in immune pathogenesis.
Main findings
 AQP11, an unorthodox water channel protein, is
expressed at Müller glia plasma cell membrane
 AQP11 decreases in a spontaneous inflammatory
retinal disease
 AQP11 probably is a channel for outward water
transport from Müller glia
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